Semaglutide
Long-acting GLP-1 receptor agonist (active ingredient of Ozempic, Wegovy and Rybelsus)
A modified version of the gut hormone GLP-1, made to last much longer. It is the active ingredient in approved prescription medicines for type 2 diabetes and weight management. Research-grade powder sold online is not those medicines and has not been checked by any regulator.
Structure
Evidence at a glance
Where the published research on Semaglutide comes from, by type of study.
Cell studies
GLP-1 receptor binding, insulin secretion and beta-cell studies.
Animal studies
Rodent and primate studies of appetite, body weight, glucose control and heart outcomes.
Human studies
Large randomised trials (SUSTAIN, STEP, SELECT) led to approval as a prescription medicine.
Research areas
What laboratories have studied Semaglutide for, and in which models. These are research questions, not proven uses.
GLP-1 receptor pharmacology
Receptor binding assaysPancreatic beta cells- Selective GLP-1 receptor agonist with high albumin binding.
- Glucose-dependent insulin secretion in cell models.
Appetite and energy balance
Rodent feeding studies- Acts on brain areas that regulate appetite in animal models.
Cardiometabolic outcomes
Large clinical trials- Studied for heart, kidney and liver outcomes in approved-drug trials.
Legal status
The approved prescription medicines and research-grade powder are legally different products. Only the licensed medicines may be supplied for human use.
United States Approved (Rx)
Approved by FDA as Ozempic, Wegovy and Rybelsus, by prescription only. Research-grade semaglutide is not the approved product, and FDA has issued 2026 warning letters to sellers of it.
United Kingdom Approved (Rx)
Licensed by MHRA as prescription-only medicines. Unlicensed products sold for human use are illegal medicines.
European Union Approved (Rx)
Authorised by the EMA as prescription medicines. Research-grade material is not covered by that authorisation.
Sport Permitted
Not on the WADA Prohibited List for 2026; WADA confirmed GLP-1 receptor agonists remain permitted on the 2027 list.
Licensed medicines
For people, the only legal route is a licensed medicine prescribed by a clinician. These are the approved products that contain Semaglutide.
Lab handling
General good practice for research materials. Follow the supplier's datasheet where it differs.
Storage
Keep the sealed material at −20 °C, dry and away from light. Let the vial reach room temperature before opening to stop condensation.
Solubility
Research grade is usually soluble in sterile water or dilute buffer. Add solvent down the vial wall and swirl gently rather than shaking.
Aliquots
Split solutions into single-use aliquots, label with lot number and date, and freeze. Avoid repeated freeze-thaw cycles.
Work out your stock solution
Stock concentration, molarity and dilutions for Semaglutide, using MW 4113.58 g/mol.
Before you buy for your lab
Tick each check as you confirm it with the supplier. Do not order until all six are done.
Questions researchers ask
What is Semaglutide?
A modified version of the gut hormone GLP-1, made to last much longer. It is the active ingredient in approved prescription medicines for type 2 diabetes and weight management. Research-grade powder sold online is not those medicines and has not been checked by any regulator.
What is the molecular weight of Semaglutide?
About 4113.58 g/mol. Use the figure on your batch certificate of analysis.
Is research-grade Semaglutide the same as Ozempic?
No. Ozempic is a licensed medicine made under regulated manufacturing. Research-grade Semaglutide sold online is a different, unchecked product for laboratory use only, and selling it for human use is illegal.
Is Semaglutide approved for human use?
No. Approved by FDA as Ozempic, Wegovy and Rybelsus, by prescription only. Research-grade semaglutide is not the approved product, and FDA has issued 2026 warning letters to sellers of it.
How should Semaglutide be stored in the lab?
Keep the sealed material cold, dry and away from light, typically at −20 °C. Once in solution, split it into single-use aliquots and freeze to avoid repeated freeze-thaw cycles.
Does this page give doses?
No. We publish laboratory and educational information only, never doses, injection guidance or treatment advice.
Sources
- PubMed: indexed Semaglutide studies
- Orrick: FDA peptide bulks list changes (April 2026)
- MHRA statement on peptide claims (via PSL Hub)
- Drugs.com: retatrutide development history
- WADA 2027 list: GLP-1 agonists remain permitted
- McDermott: FDA warning letters to online peptide sellers (2026)
- WADA Prohibited List


